Gilead Drug Combination Cures Hepatitis C in HIV Patients
Alert: HALISTER Source: BN (Bloomberg News)
Tickers GILD US (Gilead Sciences Inc) 3400398Z US (HHS Food & Drug Administration)
People Mark Sulkowski (Johns Hopkins University) Michael Saag (University of Alabama at Birmingham)
Topics AIDS Viral Hepatitis Infectious Diseases Cancers
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283